Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469748/
https://www.ncbi.nlm.nih.gov/pubmed/37664865
http://dx.doi.org/10.1155/2023/9853760
_version_ 1785099512643059712
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10469748
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104697482023-09-01 Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-08-23 /pmc/articles/PMC10469748/ /pubmed/37664865 http://dx.doi.org/10.1155/2023/9853760 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title_full Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title_fullStr Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title_full_unstemmed Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title_short Retracted: Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease
title_sort retracted: implications of ezetimibe in combination with low- to moderate-intensity atorvastatin adjuvant aspirin therapy for cerebrovascular disease
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469748/
https://www.ncbi.nlm.nih.gov/pubmed/37664865
http://dx.doi.org/10.1155/2023/9853760
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedimplicationsofezetimibeincombinationwithlowtomoderateintensityatorvastatinadjuvantaspirintherapyforcerebrovasculardisease

Ejemplares similares